Levofloxacin vs Rituximab
Levofloxacin vs Rituximab: Overview
This comparison examines the pharmacological differences between Levofloxacin and Rituximab.
Mechanism of Action
Levofloxacin: Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Levofloxacin — 6-8 hours; Rituximab — 22 days.
Chemical Properties
Molecular Formula: Levofloxacin — C18H20FN3O4.
Molecular Weight: Levofloxacin — 361.3680 g/mol.
Type: Levofloxacin — Small molecule; Rituximab — Antibody.